BOSTON & CAMBRIDGE, England--(BUSINESS WIRE)--Alchemab Therapeutics, a biotechnology company focused on the discovery and development of naturally-occurring protective antibodies and immune repertoire ...
BOSTON & CAMBRIDGE, England--(BUSINESS WIRE)--Alchemab Therapeutics, a biotechnology company focused on the discovery and development of naturally-occurring protective antibodies and immune repertoire ...
At an old biscuit factory in South London, giant mixers and industrial ovens have been replaced by robotic arms, incubators, and DNA sequencing machines. James Field and his company LabGenius aren’t ...
As of late 2021, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants associated with increased transmissibility and/or immune evasion (antibody escape) had nearly completely ...
CHAMPAIGN, Ill. — A new study shows that it is possible to use the genetic sequences of a person’s antibodies to predict what pathogens those antibodies will target. Reported in the journal Immunity, ...
Antibody treatments may be able to activate the immune system to fight diseases like Parkinson’s, Alzheimer’s and colorectal cancer, but they are less effective when they bind with themselves and ...
A new study shows that it is possible to use the genetic sequences of a person's antibodies to predict what pathogens those antibodies will target. The new approach successfully differentiates between ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results